Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
B 3.40 0.59% 0.02
ACST closed up 0.59 percent on Monday, March 18, 2024, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
20 DMA Support Bullish 0.59%
Bollinger Band Squeeze Range Contraction 0.59%
NR7 Range Contraction 0.59%
NR7-2 Range Contraction 0.59%
Narrow Range Bar Range Contraction 0.59%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 8 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
20 DMA Support about 12 hours ago
60 Minute Opening Range Breakout about 12 hours ago
10 DMA Resistance about 12 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cardiovascular Disease Lipid Drug Products Metabolic Disorders Fatty Acids Triglyceride Medical Food Cardiovascular Disorders Hypertriglyceridemia Omega 3 Fatty Acid Onemia

Is ACST a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.834
52 Week Low 1.72
Average Volume 27,023
200-Day Moving Average 2.59
50-Day Moving Average 2.89
20-Day Moving Average 3.37
10-Day Moving Average 3.40
Average True Range 0.15
RSI (14) 62.69
ADX 36.78
+DI 23.82
-DI 11.17
Chandelier Exit (Long, 3 ATRs) 3.14
Chandelier Exit (Short, 3 ATRs) 3.03
Upper Bollinger Bands 3.51
Lower Bollinger Band 3.24
Percent B (%b) 0.6
BandWidth 8.10
MACD Line 0.16
MACD Signal Line 0.19
MACD Histogram -0.0304
Fundamentals Value
Market Cap 31.96 Million
Num Shares 9.4 Million
EPS -5.65
Price-to-Earnings (P/E) Ratio -0.60
Price-to-Sales 208.39
Price-to-Book 0.35
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.48
Resistance 3 (R3) 3.47 3.44 3.46
Resistance 2 (R2) 3.44 3.42 3.44 3.46
Resistance 1 (R1) 3.42 3.41 3.43 3.43 3.45
Pivot Point 3.39 3.39 3.40 3.39 3.39
Support 1 (S1) 3.37 3.37 3.38 3.38 3.35
Support 2 (S2) 3.34 3.36 3.34 3.34
Support 3 (S3) 3.32 3.34 3.34
Support 4 (S4) 3.33